Sporty Magazine official website | Members area : Register | Sign in

Health Reform Updates: Biotech Grants, Privacy Issues And Birth Control Coverage

Sunday, November 14, 2010

Share this history on :

Main Category: Health Insurance / Medical Insurance
Also Included In: Pharma Industry / Biotech Industry;  Sexual Health / STDs;  Cancer / Oncology
Article Date: 09 Nov 2010 - 5:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated

Firms vying to tap the fund a $1 billion fund meant to catalyze research on new biologic treatments for cancer and other diseases may be disappointed in the outcome, The Washington Post reports. "[W]ith so many companies applying for a share of the money, many firms got much smaller allotments than requested and said the financial boost won't go as far as they had initially hoped. Rockville [Md.]-based RegeneRx received three grants for work on therapies to repair tissue and organ damage, totaling just over $733,000. President and chief executive J.J. Finkelstein said the company sought $5 million, the most a single company was eligible to receive," though individual projects were limited to $244,479.24 (Overly, 11/8).

Meanwhile, American Medical News reports, the federal government's Office of Personnel Management, "which manages benefits for federal employees, intends to create a giant database of medical claims information about those employees and enrollees in two programs created by the Patient Protection and Affordable Care Act. In an Oct. 27 letter, the Center for Democracy & Technology, a nonpartisan Washington, D.C.-based group that advocates for health privacy, asked the OPM for more information about its intentions, raised preliminary concerns about the idea and asked the office to delay its launch from Nov. 15" (Berry, 11/8).

And, Minnesota Public Radio notes that as "health insurance companies try to determine what the new health care reform law will require them to cover, birth control is emerging as one of the more controversial issues at stake. A panel of experts meets for the first time next week to determine whether both public and private health plans should cover the entire cost of contraception. Several medical and women's groups say women should have access to free birth control, but the Catholic church is fighting the idea" (Stawicki, 11/8).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Thank you for visited me, Have a question ? Contact on : youremail@gmail.com.
Please leave your comment below. Thank you and hope you enjoyed...

No comments:

Post a Comment